Marker Therapeutics Inc.

NASDAQ: MRKR
Share price (12/23/24): $3.42
Market cap (12/23/24): $30.5 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement

Shelf registration

Prospectus supplement for primary offering

Prospectus supplement

Initial registration of new securities

Ownership Filter

New Enterprise Associates 16, L.P.

Sandell Scott D, Baskett Forest, Walker Paul Edward, Florence Anthony A. Jr., Behbahani Ali, Makhzoumi Mohamad, New Enterprise Associates 16, L.P., NEA Partners 16, L.P., Nea 16 GP, LLC, Chang Carmen

New Enterprise Associates 16, L.P.

Eansor Norman David

News Filter

Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Provides a Clinical Update on MT-601 in Patients With Lymphoma

Awarded $9.5 Million Grant From the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients With Pancreatic Cancer

Reports Third Quarter 2024 Financial Results and Provides Business Updates

Reports Second Quarter 2024 Financial Results and Provides Business Updates

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC